Use of xenon with hypothermia for treating neonatal asphyxia
AssigneeProtexeon Limited
InventorsNicholas Franks, Mervyn Maze
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of xenon in the preparation of a medicament for the treatment of neonatal asphyxia in a neonatal subject, wherein said medicament is for use in combination with hypothermia.
Claims45
Use of xenon in the preparation of a medicament for the treatment of neonatal asphyxia in a neonatal subject, wherein said medicament is for use in combination with hypothermia.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of treating neonatal asphyxia in a mammal in need thereof, said method comprising:
- (a) administering a therapeutically effective amount of xenon to the mammal;
- and
- (b) subjecting the mammal to hypothermia.
A method of treating neonatal asphyxia in a mammal in need thereof, said method comprising administering a therapeutically effective amount of xenon to the mammal in combination with hypothermia.
Use of xenon in the preparation of a medicament for the treatment of neonatal asphyxia, wherein said treatment comprises administering to a subject simultaneously, sequentially or separately xenon in combination with hypothermia.
Use of xenon, in combination with hypothermia, for the treatment of neonatal asphyxia.
A method of treating neonatal asphyxia in a mammal in need thereof, said method comprising:
- (a) administering a therapeutically effective amount of xenon to the mother of the mammal prior to and/or during labour;
- and
- (b) subjecting the mammal to hypothermia after birth.
(canceled)
Dependencies are inferred from the claim text.